Related Experiment Video
Updated: Oct 19, 2025

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity
Junwei Hou1, Jung-Mao Hsu2, Mien-Chie Hung3
1Xiangya Cancer Center, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha 410008, Hunan, China; Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Xiangya Road 87, Changsha 410008, Hunan, China; Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha 410008, Hunan, China; Department of Molecular and Cellular Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Abstract:
Canonically, gasdermin D (GSDMD) cleavage by caspase-1 through inflammasome signaling triggers immune cell pyroptosis (ICP) as a host defense against pathogen infection. However, cancer cell pyroptosis (CCP) was recently discovered to be activated by distinct molecular mechanisms in which GSDMB, GSDMC, and GSDME, rather than GSDMD, are the executioners. Moreover, instead of inflammatory caspases, apoptotic caspases and granzymes are required for gasdermin protein cleavage to induce CCP. Sufficient accumulation of protease-cleaved gasdermin proteins is the prerequisite for CCP. Inflammation induced by ICP or CCP results in diametrically opposite effects on antitumor immunity because of the differential duration and released cellular contents, leading to contrary effects on therapeutic outcomes. Here, we focus on the distinct mechanisms of ICP and CCP and discuss the roles of ICP and CCP in inflammation and antitumor immunity, representing actionable targets.
Insights
Immune cell pyroptosis (ICP) and cancer cell pyroptosis (CCP) utilize different gasdermins and caspases. While ICP involves GSDMD, CCP uses GSDMB, GSDMC, or GSDME, impacting antitumor immunity differently.
Area of Science:
- Immunology
- Cell Biology
- Molecular Mechanisms
Background:
- Gasdermin D (GSDMD) cleavage by caspase-1 initiates immune cell pyroptosis (ICP) for pathogen defense.
- Cancer cell pyroptosis (CCP) involves distinct mechanisms, utilizing GSDMB, GSDMC, or GSDME as executioners.
Purpose of the Study:
- To elucidate the distinct molecular mechanisms underlying ICP and CCP.
- To analyze the differential roles of ICP and CCP in inflammation and antitumor immunity.
- To identify actionable therapeutic targets based on pyroptosis pathways.
Main Methods:
- Comparative analysis of gasdermin family members (GSDMD, GSDMB, GSDMC, GSDME) in pyroptosis.
- Investigation of caspase and granzyme involvement in CCP induction.
- Assessment of inflammatory and antitumor immune responses elicited by ICP and CCP.
Main Results:
- CCP is triggered by apoptotic caspases and granzymes, distinct from the inflammatory caspases activating ICP.
- Accumulation of protease-cleaved gasdermin proteins is essential for CCP.
- ICP and CCP induce inflammation with opposing effects on antitumor immunity and therapeutic outcomes.
Conclusions:
- ICP and CCP represent distinct cellular death pathways with divergent impacts on antitumor immunity.
- Understanding these differences offers novel therapeutic strategies targeting pyroptosis in cancer and infection.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Apoptosis
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...

